UK watchdog punts paroxetine to CJEU

Appeals brought by Actavis, Mylan’s Generics UK, Merck KGaA and Xellia, as well as by originator GlaxoSmithKline (GSK), against fines imposed by the UK’s Competition and Markets Authority (CMA) over paroxetine patent settlements have been referred to the Court of Justice for the European Union (CJEU).